ASSOCIATION OF ANTITHROMBIN LEVELS WITH EFFICACY OF FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A OR B, WITH AND WITHOUT INHIBITORS: A PREDICTIVE MODELING APPROACH G Young, K Kavakli, M Shen, A Srivastava, J Sun, H Tran, J Chi, A Youn, M Puurunen, SW Pipe

SURGICAL EXPERIENCE IN PEOPLE WITH HEMOPHILIA A OR B WITH AND WITHOUT INHIBITORS RECEIVING FITUSIRAN Alok-Srivastava, Pencho-Georgiev, Toshko-Lissitchkov, M V-Ragni, Juliana-Aragao, L A-Menapace, Yuqian-Shen, Marja-Puurunen, Marek-Demissie, S W-Pipe

SAFETY AND EFFICACY OF THE FITUSIRAN REVISED ANTITHROMBIN-BASED DOSE REGIMEN IN PEOPLE WITH HAEMOPHILIA A OR B, WITH OR WITHOUT INHIBITORS (ATLAS-OLE) Guy-Young, Kaan-Kavakli, S W-Pipe, Alok-Srivastava, Juliana-Aragao, L A-Menapace, Chuanwu-Zhang, Marja-Puurunen, Marek-Demissie, Gili-Kenet